ABP
Price
$0.26
Change
-$0.02 (-7.14%)
Updated
Aug 6, 04:22 PM (EDT)
Capitalization
16.83M
SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
Interact to see
Advertisement

ABP vs SLXN

Header iconABP vs SLXN Comparison
Open Charts ABP vs SLXNBanner chart's image
Abpro Holdings
Price$0.26
Change-$0.02 (-7.14%)
Volume$4.27K
Capitalization16.83M
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
ABP vs SLXN Comparison Chart in %
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. SLXN commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a Buy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (ABP: $0.28 vs. SLXN: $8.86)
Brand notoriety: ABP and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 486% vs. SLXN: 38%
Market capitalization -- ABP: $16.83M vs. SLXN: $5.13M
ABP [@Biotechnology] is valued at $16.83M. SLXN’s [@Biotechnology] market capitalization is $5.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, ABP is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 7 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • ABP’s TA Score: 7 bullish, 3 bearish.
  • SLXN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABP is a better buy in the short-term than SLXN.

Price Growth

ABP (@Biotechnology) experienced а -14.38% price change this week, while SLXN (@Biotechnology) price change was -28.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

ABP is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABP($16.8M) has a higher market cap than SLXN($5.13M). SLXN YTD gains are higher at: -70.614 vs. ABP (-84.531). ABP has higher annual earnings (EBITDA): -10.08M vs. SLXN (-16.96M). ABP has less debt than SLXN: ABP (3.25M) vs SLXN (3.48M). ABP has higher revenues than SLXN: ABP (183K) vs SLXN (0).
ABPSLXNABP / SLXN
Capitalization16.8M5.13M327%
EBITDA-10.08M-16.96M59%
Gain YTD-84.531-70.614120%
P/E RatioN/AN/A-
Revenue183K0-
Total Cash1.26MN/A-
Total Debt3.25M3.48M93%
TECHNICAL ANALYSIS
Technical Analysis
ABPSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
17%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
8%
Momentum
ODDS (%)
Bullish Trend 2 days ago
43%
Bearish Trend 2 days ago
20%
MACD
ODDS (%)
Bullish Trend 2 days ago
26%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 9 days ago
50%
Bullish Trend 10 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
18%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
17%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFG2.940.14
+5.00%
Uni-Fuels Holdings Ltd
AMN17.490.06
+0.34%
AMN Healthcare Services
AMBO2.85N/A
-0.11%
Ambow Education Holding Ltd
AMCX5.98-0.03
-0.50%
AMC Networks
PATH11.22-0.12
-1.06%
UiPath

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and FBIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and FBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
+15.81%
FBIO - ABP
31%
Poorly correlated
+1.33%
NGNE - ABP
30%
Poorly correlated
-1.24%
QSI - ABP
27%
Poorly correlated
N/A
MNKD - ABP
26%
Poorly correlated
+1.79%
ALLO - ABP
25%
Poorly correlated
+1.82%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More